Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5873_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
27 Мб
Скачать
SUMMARY OF DRUGS USED FOR GASTRIC ULCERS AND GASTRO-OESOPHAGEAL REFLUX DISEASE
322 Chapter 12 Upper gastrointestinal tract disorders
Therapeutic class Drugs Mechanism of action Common clinical uses Comments Common adverse drug
reactions
Antacids Magnesium and aluminium
H2-receptor antagonists
Proton pump inhibitors
Prostaglandin analogues
Cytoprotective agents
Antibiotics Amoxicillin
hydroxide combinations
Ranitidine Famotidine Cimetidine Nizatidine
Omeprazole Esomeprazole Pantoprazole Rabeprazole Lansoprazole
Misoprostol Mimics effects of protective
Bismuth chelate Mode of action unclear
Sucralfate Forms a physical barrier by
Clarithromycin Metronidazole
Reduce acidity of the stomach through neutralization
Competitive antagonist at H2 receptor
Irreversible inhibition of proton pump (H+/K+-ATPase)
prostaglandins to increase mucus and bicarbonate production and decrease acid secretion
Precipitated bismuth may coat damaged area by binding to exposed glycoproteins Antibacterial action through disruption of outer membrane proteins
binding to exposed glycoproteins or proteins in damaged area
Used in triple therapy for eradication of H. pylori. See Drug summary table in Chapter 22
Dyspepsia Chelate some drugs to reduce
Gastric and duodenal ulcer Gastro-oesophageal reflux disease
Gastric and duodenal ulcer Gastro-oesophageal reflux disease Zollinger–Ellison syndrome H. pylori eradication
Gastric and duodenal ulcer Contraindicated in pregnancy as
Gastric and duodenal ulcer H. pylori eradication
Gastric and duodenal ulcer Constipation
their absorption Sometimes contains simethicone/dimethicone
May reduce absorption of drugs that require an acidic environment Cimetidine inhibits cytochrome P450 enzymes, leading to interactions
May reduce absorption of drugs requiring acidic environment for absorption
uterine contraction can induce labour
Added to triple therapy in H. pylori eradication when standard triple therapy has failed
Diarrhoea (magnesium) Constipation (aluminium)
Diarrhoea Dizziness Headache Gynaecomastia (cimetidine)
GI disturbances Headache Dizziness
Diarrhoea Abdominal pain Dizziness Menorrhagia
Nausea and vomiting Blackens faeces and tongue
Back pain Bezoar formation (obstruction in the stomach)
SUMMARY OF DRUGS USED FOR NAUSEA AND VOMITING
12.6 Antiemetic therapy 323
Therapeutic class Drugs Mechanism of action Common clinical uses Comments Common adverse drug
reactions
First-generation antihistamines
Antimuscarinics Hyoscine hydrobromide Blocks muscarinic receptors (including
Dopamine receptor antagonists
Selective 5-HT3 receptor antagonists
Neurokinin receptor antagonists
Cinnarizine Cyclizine Promethazine Diphenhydramine
First-generation antipsychotics:
Chlorpromazine Droperidol Haloperidol Levomepromazine
Metoclopramide Domperidone
Ondansetron Dolasetron Granisetron Palonosteron Tropisetron
Aprepitant, Fosaprepitant
Competitive antagonists at the H1 receptor
those involved in transmission between inner ear and emesis centre)
Antagonist at D2 dopamine receptors in chemoreceptor trigger zone Block additional receptors, including serotonin (5-HT2), histamine (H1), and muscarinic (M1) receptors
D2 dopamine receptor antagonists (Greater selectivity for D2 receptors than first-generation antipsychotics)
Antagonists at 5-HT3 receptor in GI tract and CTZ
Block actions of substance P through antagonism of neurokinin-1 receptors in CTZ and emesis centre
See Drug summary table in Chapter 10
Motion sickness Vertigo Hypersalivation
Nausea and vomiting Psychoses Intractable hiccup Choreas
Nausea and vomiting (particularly that induced by chemotherapy or radiotherapy) Gastro-oesophageal reflux disease Motility stimulant
Nausea and vomiting Motility stimulant
Nausea and vomiting associated with chemotherapy
Available as transdermal patch
Levomepromazine has additional analgesic properties
Promote acetylcholine release in myenteric plexus, enhancing peristalsis (prokinetic action) Domperidone does not cross blood–brain barrier, so has fewer CNS side effects, including less sedation
Superior for highly emetogenic chemotherapy/ post surgery
Fosaprepitant is a pro-drug of aprepitant It reduces metabolism of dexamethasone and methylprednisolone
Dry mouth Blurred vision Urinary retention Constipation
Sedation Hypotension When use is prolonged, extrapyramidal effects: Acute dystonia (abnormal movements), tardive dyskinesia (involuntary movement of tongue, jaw and lips), and parkinsonism (see Chapter 17)
Metoclopramide:
Sedation Extrapyramidal effects (as above) Gynaecomastia Menstrual changes
Domperidone:
Drowsiness Dry mouth Malaise
Constipation Headache Flushing Dizziness
Anorexia Severe fatigue Constipation Diarrhoea
CNS, central nervous system; GI, gastrointestinal; CTZ, chemoreceptor trigger zone.

WORKBOOK 9

Gastric ulcers and gastro-oesophageal reflux disease
Dr Carter Brown: a simplified case history
After a short stay in accident and emergency, Dr Carter Brown is being wheeled to the gastrointestinal ward at Glenfield Hospital.
He has been brought into hospital by his mother, who was shocked by his appearance when she had called in to see him. She has been keeping an eye on him since his recent divorce, which hit him hard. She is worried about the number of takeaways he has been having, and she thinks he has definitely been drinking too much.
She was horrified to find him lying on the sofa, clutching his stomach in obvious agony. He had then been violently sick. The appearance of the vomit, which looked like coffee grounds,
alarmedthemboth,andCarterrealizedhewasmoreillthanhehadadmitted.
He felt too ill to protest when his mother bundled him into the car and drove him to hospital, although he was uncomfortable with the idea of being a patient in the hospital where he used to work.
A table of clinical clerking abbreviations is given on page xviii.
CLINICAL CLERKING FOR DR CARTER BROWN AT ACCIDENT AND EMERGENCY DEPARTMENT
Age: 35 years
PC: Gnawing abdominal pain accompanied by vomit with the appearance of coffee grounds
The appearance of the vomit indicates the presence of blood that has coagulated in the gastric juices.
HPC: Intermittent stomach pains over 2 days, gradually becoming more severe. Similar, though not as severe, pains over the last 6 months. Initially tried over-the-counter antacids. Following diagnosis of gastro-oesophageal reflux disease, received medication, which helped until current episode. Since yesterday, he has had several dark-coloured, very loose bowel movements.
PMH:
Gastro-oesophageal reflux disease
Recent injury sustained in a domestic incident
Before the diagnosis of gastro-oesophageal reflux disease, Dr Brown had not had any significant illness
WORKBOOK 9 Gastric ulcers and gastro-oesophageal reflux disease 325
DH:
1) Ranitidine for gastro-oesophageal reflux disease
2) Ibuprofen (prescribed for a recent injury)
3) Gaviscon®: occasionally
Until recently his gastro-oesophageal reflux disease has been controlled by ranitidine, and occasional doses of Gaviscon®. Since starting ibuprofen for an acute injury, his symptoms have no longer been controlled
SH: 35-year-old medical doctor. Recently divorced, he lives alone. Smokes 20 cigarettes a day and drinks about 30 units of alcohol per week.
Smoking impairs ulcer healing and promotes recurrence. Alcohol and stress are implicated as predisposing factors in peptic ulcer disease.
O/E:
1) Pale, sweating, and shocked
2) Blood pressure = 115/60 mmHg (ideal: <140/90 mmHg)
3) Pulse = 98 beats per minute (normal: 60 beats/min)
Diarrhoea and vomiting have led to significant loss of fluids which has resulted in signs of shock (pale sweaty skin, low blood pressure, and a raised pulse).
4) Abdomen = tender
5) Rectal examination = melaena
Melaena: passage of black tarry faeces, a result of bleeding into the upper gastrointestinal tract.
6) Weight = 120 kg
7) Height = 185 cm
Carter is overweight. Excess weight is a risk factor for gastro-oesophageal reflux disease.
Biochemistry:
All within range except:
1) Haemoglobin = 10 g/dl (reference: male 13.5–17 g/dl; female 11.5–15 g/dl)
2) Mean cell volume = 72 fl (reference 80–90 fl)
3) Haematocrit = 31% (reference male 39–50%; female 36–44%)
Haemoglobin level is the most commonly used index for detecting anaemia (defined as a lower than normal O2-carrying capacity of the blood). The loss of blood due to gastric bleeding has resulted in iron-deficiency anaemia.
Mean cell volume is the average volume of a red blood cell (erythrocyte). Where this is low a diagnosis of microcytic anaemia is made, as seen in iron-deficient states.
Haematocrit: the proportion of blood volume occupied by all blood cells. As more than 99% of the cells are erythrocytes, this index essentially represents the proportion of blood volume occupied by erythrocytes. This value is low in all forms of anaemia.
Together these three readings indicate that Carter has iron-deficiency anaemia as a result of gastric bleeding.
Provisional diagnosis: Gastric ulcer
326 Chapter 12 Upper gastrointestinal tract disorders
Plan:
• Halfhourlyobservations
• Endoscopy
• [13C] Urea breath test
• Intravenousuids
• Ranitidine
• Metoclopramide,asrequired
• Ferroussulfate
• Discontinueibuprofen
1) Endoscopy: A procedure using a flexible tube with a light source and camera. The tube is inserted through the mouth and enables visualization of the oesophagus, stomach, and duodenum.
2) [13C] or [14C]Urea breath test is used to detect Helicobacter pylori infection. This test depends on the conversion of urea by bacterial urease enzymes into ammonia and CO2. The patient is given urea labelled with a carbon isotope. Where infection is present, labelled CO2 is excreted in the patient’s breath and can be detected.
3) Metoclopramide: a D2 dopamine receptor antagonist which targets receptors in the chemoreceptor trigger zone to control vomiting.
4) Ferrous sulfate: to correct anaemia resulting from blood loss, and replenish the body’s iron stores.
5) Carter must stop taking the non-steroidal anti-inflammatory drug ibuprofen. This class of drug can cause peptic ulcers through inhibition of prostaglandin production. Prostaglandins, particularly PGE2, have beneficial protective properties in the gastric mucosa.
Although it is late, Carter’s mum insists on staying with him while they wait for the doctors. She is worried, and cannot understand why her son is so sick.
1) List and explain five ways in which the stomach protects itself against the actions of gastric juices.
2) Name two substances found in the stomach that would destroy the mucosa in the absence of the
protective features mentioned above.
3a) Name the three main endogenous signals which promote acid secretion by parietal cells.
3b) How do they change parietal cell function?
The gastroenterologist finally comes to see Carter.
Although he knows Carter is a doctor, he explains both to him and his mum what he believes
theproblemtobe.Carter’smumispuzzledasshelistenstohimtalkaboutpumpsand
prostaglandins.
4a) What is the name of the pump involved in the secretion of acid by the parietal cell?
4b) What is the source of the protons (H+ ) transported by this pump?
WORKBOOK 9 Gastric ulcers and gastro-oesophageal reflux disease 327
The doctor considers it likely that a combination of factors has contributed to Carter developing an ulcer; the results of tests to confirm this diagnosis are pending. The doctor talks about mucosal damage, and a lack of mucosal protection. Carter and the gastroenterologist discuss his use of the non-steroidal anti-inflammatory drug ibuprofen.
5) What are the two most common causes of peptic ulcers?
6) Explain how taking ibuprofen may have contributed to the development of a peptic ulcer in Carter’s case.
7a) What is Helicobacter pylori?
7b) Explain how H. pylori infection can lead to the formation of a peptic ulcer.
Carter has been given metoclopramide to help prevent vomiting.
8a) Explain the mechanism of action of metoclopramide in preventing vomiting.
8b) Is there another action of metoclopramide which may benefit Carter?
8c) What are the main side effects of metoclopramide, and which groups of patients are most likely to
be affected?
The doctor asks Carter about his symptoms of gastro-oesophageal reflux disease.
9) What is gastro-oesophageal reflux disease, and what are its usual symptoms?
10) What is the main objective in the treatment of gastro-oesophageal reflux disease?
Carter informs the gastroenterologist that he was prescribed ranitidine by his GP for his symptoms.
11a) What class of drug does ranitidine belong to?
11b) How does this drug act to reduce symptoms of gastro-oesophageal reflux disease?
The doctor tells Carter that if the test results for H. pylori infection are positive, he will be prescribed a combination of drugs instead of ranitidine.
They expect the results within an hour. Carter is encouraged to rest. The gastroenterologist has to leave, but he tells Carter that another doctor from his team will come round later to explain the results.
Carter’s mum finally agrees to go home, after being reassured that she can phone at any time to find out how he is.
Two hours later Carter almost passes out when he is woken up by his ex-wife, Dr Knight, who is now on the gastroenterology team. She acts very professionally and explains that the endoscopy has confirmed an ulcer and that the urea breath test has detected H. pylori infection.
328 Chapter 12 Upper gastrointestinal tract disorders
She explains to Carter that he will be given triple therapy to eradicate H. pylori, and to promote
healingoftheulcer.Thiswillconsistofaprotonpumpinhibitor,lansoprazole,andtwo
antibiotics, clarithromycin and amoxicillin.
12) Explain the rationale for triple therapy in the treatment of gastric ulcers where H. pylori is detected.
13) Explain the mechanism of action of proton pump inhibitors.
14) Why do proton pump inhibitors decrease stomach acidity more effectively than histamine H2
receptor antagonists?
DrKnighttellsCarterthatowingtothesizeofhisulcerhewillhavetostayinhospital.She
leaves after discussing Carter’s medication with the nurses.
Carter is unhappy about having to stay in hospital. To make matters worse, the triple therapy fails to eradicate the H. pylori infection after 7 days.
Thedrugcombinationischangedtolansoprazole,bismuthchelate,amoxicillin,and metronidazole.
15) Explain the action of bismuth chelate in H. pylori-induced peptic ulcer.
After one week on this combination, Carter finally gets better and is able to go home.
Although he is now feeling better, he is depressed about the state of his personal life, and is drinking and smoking more than ever.
Three months later he starts experiencing symptoms of gastritis. He decides to buy antacids over the counter from his local pharmacy. The pharmacist recommends an antacid that combines aluminium and magnesium salts. The antacid works, and he starts to feel better.
16) Explain why antacids are beneficial in alleviating symptoms of gastritis.
17) Why are antacids that combine magnesium and aluminium salts better than those with either agent alone?
18) How are mucosal protective agents beneficial in the treatment of gastritis and gastric ulcers?
Over time Carter develops increasing abdominal discomfort and pain, which he is less able to manage with antacids. He makes an appointment to see his GP. They have a frank discussion, and the GP warns Carter that unless he modifies his lifestyle, it is likely that he will have to take a proton pump inhibitor long term.
When Carter picks up his prescription, the pharmacist tells him to take the proton pump inhibitor with breakfast, and to ensure that he swallows the tablet whole.
19) Explain why the proton pump inhibitor tablet should be swallowed whole.
20) What are the potential problems with long-term proton pump inhibitor use?
Chapter 13
Disorders of the lower gastrointestinal tract
Useful terms for this topic
Enterocytes: Epithelial cells lining the intestines,
specialized for absorption.
Gastroenteritis: Inammation of the stomach and
intestinal walls typically resulting from bacterial or viral infections, and causing vomiting and diarrhoea.
Irritable bowel syndrome: A common long-term
condition affecting the colon. Characterized by abdominal pain, discomfort, and altering bowel habits.
Laxative: A drug that promotes emptying of the
bowels.
e two most commonly encountered disorders arising from dysfunction of the lower gastrointestinal tract, diarrhoea and constipation, are familiar to more or less everybody at some point in their lives. ese conditions, which can contribute signicantly to feelings of poor
health, are themselves symptoms rather than diseases, arising from a number of causes. e two conditions can be interrelated; for example, constipation can be the cause of diarrhoea owing to irritants released from stagnant faeces in the intestines. As patterns of bowel movements vary enormously between individuals, these conditions are diagnosed with reference to the individual’s normal pattern.
Irritable bowel syndrome (IBS) is a common but lessclearly diagnosed problem aecting the lower gastrointestinal tract, specically the colon. It features agroup of symptoms including both diarrhoea and constipation, as well as frequent abdominal discomfort and pain. e condition is considered further in Workbook 10 at the end of this chapter, as our ctional patient Helen suers such symptoms over a prolonged period, and is diagnosed with IBS.

13.1 The lower gastrointestinal tract

e lower gastrointestinal tract refers to that section of the digestive system from the small intestine through to theanus. e function of the small intestine is to continue the digestion of carbohydrates and proteins which began in the stomach, and to digest fats. A number of hormones regulate the release of secretions from accessory organs. ese secretions enable the digestive process (see also Introduction to Part 4).
• e pancreas releases enzymes that digest the three
primary categories of food: carbohydrates, proteins andfats.
• e liver produces bile. is contains bile salts that act
as detergents to emulsify fats, breaking them into
smaller droplets, and facilitating their digestion by pancreatic enzymes (lipases).
Once digestion is complete, the resulting small molecules can be absorbed. is takes place largely in the duodenum and jejunum regions of the small intestine, where most of the ingested water, vitamins, and electrolytes are also absorbed. (Some substances are absorbed directly by the stomach, e.g. alcohol and some drugs, including non-steroidal anti-inammatory drugs.)
Over the course of a day a huge volume of uid, approximately 8–10 litres, enters the small intestine, of which only around 2 litres is dietary in origin; the remainder is derived from secretions (saliva, gastric
330 Chapter 13 Disorders of the lower gastrointestinal tract
OH
Box 13.1
Water absorption in the intestine
Blood vessel Enterocyte
Lumen of
intestine
1
+
K
+
Na
+
Na
SGLT1
2
Glucose
3
Glucose
4
H
2
Figure a
1. The Na+/K+-ATPase on the basolateral membrane actively pumps Na+ out of the cell,
against a concentration gradient (primary active transport).
2. A concentration gradient for Na+ is established, which favours the entry of Na+ into the cell. This in turn drives the transport of glucose across the brush border of the epithelial cells lining the small intestine. This secondary active transport is carried out by the sodium and glucose co-transporter SGLT1. Na+ binds to the luminal side of the SGLT1 protein and causes a conformational change, increasing its affinity for glucose, which is carried into the cell against its concentration gradient. Na+ and glucose are thereby taken up by the epithelial cells. Movement of additional ions, such as uptake of Cl–, is also favoured by the Na+ concentration gradient (not shown).
3. A second glucose transporter GLUT-2, on the basolateral membrane of the intestinal epithelial cells, allows diffusion of glucose out of the cell to enter the plasma. The glucose travels along its concentration gradient by facilitated diffusion.
4. The resulting elevation in glucose and Na+ concentration to the capillary side of the basolateral membrane creates a localized high osmotic pressure. This passively draws water from the gut lumen across the cell, and into the plasma.
O
2
and pancreatic secretions, etc.). is uid must be reabsorbed into the plasma across the wall of the small intestine by specialized cells called enterocytes (seeBox 13.1).
e mucosal layer of enterocytes is adapted for its role of absorption in two broad ways.
1. e enterocytes possess a number of specialized transport mechanisms responsible for the uptake ofspecic molecules
2. e cells are arranged as tiny projections (villi) poking into the lumen, which increase the surface area for absorption. is is increased still further by even
13.2 Diarrhoea 331
smaller hair-like projections (microvilli/brush border) on the luminal surface of each enterocyte. Together, these modications increase the absorptive surface area 600-fold.
Where the volume of uid absorbed does not match that secreted (for instance, where a person is suering with diarrhoea), dehydration, electrolyte depletion, and acid– base imbalance can ensue.

13.2 Diarrhoea

Diarrhoea is a symptom rather than a disease, and can be caused by numerous factors including an underlying medical condition, as a side eect of drugs, or from a psychological state such as anxiety. Most cases of diarrhoea in Western countries, though, are the result of viral and bacterial infections, notably Campylobacter (the most common cause of food poisoning in the UK) and norovirus in adults, and rotavirus in children. Gastroenteritis describes the inammation of the stomach and intestinal walls that can result from such infections.
e presence of an infectious agent in the gut causes local irritation of the small intestine walls. is increases the peristaltic action of the intestinal smooth muscles, increasing the speed of transit of the gut contents and not allowing enough time for absorption. rough a variety of dierent mechanisms, pathogens increase secretions of electrolytes and water into the small intestine, and some also reduce absorption. Cholera toxin, for instance, promotes secretion into the gut by stimulating adenylyl cyclase activity in the intestinal epithelial cells. It does so by causing a persistent activation of Gs subunits through an inhibition of the inbuilt GTPase activity, which ordinarily returns the subunit to its inactive state (see Chapter 2, Section 2.2.4). e result is an increase in cellular cyclic AMP levels which, through activation of protein kinase A, massively increases the conductance of Cl– into the gut lumen. Other diarrhoea-inducing microbes act through other mechanisms to increase Cl– secretion, or to reduce Na+ absorption. Importantly, particularly in terms of therapy, microbes which induce diarrhoea, including cholera toxin, do not aect SGLT-1 (see Box 13.1).
In Western countries nearly all cases of diarrhoea are acute and self-limiting. Studies in these areas have indicated that around 5–7% of people report having had diarrhoea in the previous 4 weeks, with the greatest prevalence amongst the youngest (almost 1 in 10 children
e volume of gut contents normally reaching the large intestine is around 500 ml. is is made up of indigestible food residues, excreted substances (e.g. certain drugs), and some water. e role of this section of the digestive tract is to further remove water and salt, and to compact the contents to form faeces for elimination. If the waste is retained for a prolonged period in the large intestine, too much water may be removed, resulting in constipation.
under 5 years); these same studies found that only 1 in 5 seek medical care. In developing countries, however, diarrhoea can be chronic and/or life-threatening; diarrhoea-inducing infections, mostly contracted by drinking contaminated water, are one of the leading causes of infant death, as a result of dehydration.
Alternatively, diarrhoea can be caused by the presence of non-absorbable substances in the digestive tract lumen creating an osmotic gradient, which draws water into the gut and retains it there (osmotic diarrhoea). is arises in lactose-intolerant individuals, where a deciency in the enzyme lactase leads to undigested lactose remaining in the intestine. It is also how diarrhoea is caused by antacid treatment with magnesium salts (see Chapter 12, Section
12.4.1), or by excessive consumption of foods containing articial sweeteners (e.g. xylitol and mannitol). When the causative agent is no longer present, the condition generally resolves.
Diarrhoea is diagnosed with reference to a person’s normal bowel habits. e clinical diagnosis of diarrhoea is increased frequency of watery or liquid stools, often with a stool mass above 200 g per day. Where the condition continues beyond 14 days, it is classied as persistent. If blood is present, a diagnosis of dysentery is made; this is usually caused by a bacterial, protozoan, or parasitic infection.
13.2.1 Treatment of diarrhoea
Mild to moderate gastroenteritis is usually self-limiting, lasting only 24–48 hours. Aected individuals should maintain adequate uid intake to compensate for water and electrolyte loss. Very young and frail elderly patients are at particular risk of dehydration, and this can mean that even moderate diarrhoea is potentially life­threatening. Where dehydration is a danger, oral rehydration therapy is recommended to prevent, or reverse, depletion of uid and electrolytes.